Pathophysiology Quiz: Hypoglycemia And Counterregulation
20 questions · exam conditions
0:00
Hypoglycemia And CounterregulationQuestion 1 of 20

During a prolonged fast (e.g., >24 hours), hepatic glycogen stores are depleted. In this state, the ability of which counterregulatory hormone to raise blood glucose is most significantly diminished?

Epinephrine
Growth Hormone
Cortisol
Glucagon
← Back to quizzes

Pathophysiology Quiz

Pathophysiology Quiz: Hypoglycemia And Counterregulation

Practice Hypoglycemia And Counterregulation in Pathophysiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Hypoglycemia And Counterregulation, giving you a quick way to practice the rules, question types, and explanations that matter most for Pathophysiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

During a prolonged fast (e.g., >24 hours), hepatic glycogen stores are depleted. In this state, the ability of which counterregulatory hormone to raise blood glucose is most significantly diminished?

  1. Epinephrine
  2. Growth Hormone
  3. Cortisol
  4. Glucagon (correct answer)
Explanation: When you encounter questions about counterregulatory hormones during fasting, focus on each hormone's specific mechanism for raising blood glucose. The key insight here is that some mechanisms depend on available glycogen stores while others don't. Glucagon primarily raises blood glucose through glycogenolysis—breaking down hepatic glycogen into glucose. This is its most potent and immediate mechanism. During prolonged fasting when glycogen stores are depleted, glucagon loses its primary tool for rapidly elevating blood glucose. While glucagon can also stimulate gluconeogenesis (making new glucose), this process is much slower and less efficient than glycogenolysis, making glucagon significantly less effective in the glycogen-depleted state. Let's examine why the other options remain effective: Epinephrine (A) has multiple mechanisms including lipolysis (breaking down fat for alternative fuel), muscle glycogenolysis, and stimulating gluconeogenesis—none of which require hepatic glycogen. Growth hormone (B) primarily works through lipolysis and promoting gluconeogenesis over hours to days, independent of glycogen stores. Cortisol (C) is the master gluconeogenic hormone, stimulating new glucose production from amino acids and other substrates—a process that doesn't rely on existing glycogen. The critical distinction is that glucagon is heavily dependent on glycogen availability for its primary mechanism, while the other hormones utilize alternative pathways that remain functional during prolonged fasting. Study tip: Remember that glucagon = glycogen breakdown first, while other counterregulatory hormones have glycogen-independent mechanisms. This makes glucagon uniquely vulnerable when glycogen stores are exhausted.

Question 2

During a prolonged fast (e.g., >24 hours), hepatic glycogen stores are depleted. In this state, the ability of which counterregulatory hormone to raise blood glucose is most significantly diminished?

  1. Epinephrine
  2. Growth Hormone
  3. Cortisol
  4. Glucagon (correct answer)
Explanation: When you encounter questions about counterregulatory hormones during fasting, focus on each hormone's specific mechanism for raising blood glucose. The key insight here is that some mechanisms depend on available glycogen stores while others don't. Glucagon primarily raises blood glucose through glycogenolysis—breaking down hepatic glycogen into glucose. This is its most potent and immediate mechanism. During prolonged fasting when glycogen stores are depleted, glucagon loses its primary tool for rapidly elevating blood glucose. While glucagon can also stimulate gluconeogenesis (making new glucose), this process is much slower and less efficient than glycogenolysis, making glucagon significantly less effective in the glycogen-depleted state. Let's examine why the other options remain effective: Epinephrine (A) has multiple mechanisms including lipolysis (breaking down fat for alternative fuel), muscle glycogenolysis, and stimulating gluconeogenesis—none of which require hepatic glycogen. Growth hormone (B) primarily works through lipolysis and promoting gluconeogenesis over hours to days, independent of glycogen stores. Cortisol (C) is the master gluconeogenic hormone, stimulating new glucose production from amino acids and other substrates—a process that doesn't rely on existing glycogen. The critical distinction is that glucagon is heavily dependent on glycogen availability for its primary mechanism, while the other hormones utilize alternative pathways that remain functional during prolonged fasting. Study tip: Remember that glucagon = glycogen breakdown first, while other counterregulatory hormones have glycogen-independent mechanisms. This makes glucagon uniquely vulnerable when glycogen stores are exhausted.

Question 3

A patient with type 1 diabetes reports decreasing awareness of hypoglycemia, a phenomenon known as hypoglycemia-associated autonomic failure (HAAF). Which pathophysiological change is the central mechanism underlying this condition?

  1. A downward shift in the glycemic threshold required to trigger the counterregulatory catecholamine response. (correct answer)
  2. A permanent desensitization of hypothalamic glucose-sensing neurons due to recurrent neuroglycopenia.
  3. Progressive autoimmune destruction of the adrenal medulla, impairing epinephrine synthesis.
  4. Cerebral adaptation through upregulation of GLUT1 transporters, making the brain immune to low glucose.
Explanation: HAAF is a functional, not structural, disorder characterized by adaptation to recurrent hypoglycemia. The key mechanism is that the glucose thresholds for initiating autonomic symptoms and counterregulatory hormone release (especially epinephrine) are shifted to lower plasma glucose concentrations. This means a more severe level of hypoglycemia is required to trigger the warning symptoms and hormonal defense, leading to unawareness.

Question 4

A patient with panhypopituitarism is deficient in both growth hormone (GH) and ACTH (leading to secondary cortisol deficiency). This patient's susceptibility to hypoglycemia during a prolonged fast is exacerbated compared to a patient with isolated cortisol deficiency because the absence of GH further impairs which counterregulatory mechanism?

  1. The rapid stimulation of hepatic glycogenolysis in response to acute hypoglycemia.
  2. The immediate suppression of insulin secretion when blood glucose begins to fall.
  3. The restraint of glucose utilization by peripheral tissues like muscle and fat. (correct answer)
  4. The paracrine inhibition of somatostatin secretion within the pancreatic islets.
Explanation: Both cortisol and growth hormone are 'slow' counterregulatory hormones that are crucial during prolonged fasting. A primary role for both is to induce a state of insulin resistance in peripheral tissues (muscle and fat), thereby decreasing their glucose uptake and 'sparing' glucose for the brain. The absence of both hormones severely impairs this glucose-sparing effect and also reduces substrate availability for gluconeogenesis, making hypoglycemia more profound than with cortisol deficiency alone.

Question 5

A patient with chronic alcohol use disorder and malnutrition is found to be profoundly hypoglycemic (35 mg/dL). The metabolism of ethanol increases the cytosolic NADH/NAD+ ratio in hepatocytes. This biochemical change directly impairs counterregulation by inhibiting which specific metabolic process?

  1. The conversion of gluconeogenic precursors like lactate and pyruvate to phosphoenolpyruvate. (correct answer)
  2. The activity of glycogen phosphorylase, thereby preventing hepatic glycogenolysis.
  3. The transport of glucose out of the hepatocyte via GLUT2 transporters.
  4. The release of glucagon from pancreatic alpha cells in response to low glucose.
Explanation: Ethanol metabolism by alcohol dehydrogenase and aldehyde dehydrogenase consumes NAD+ and generates excess NADH. The high NADH/NAD+ ratio inhibits gluconeogenesis by shunting precursors away from glucose production; for example, it favors the conversion of pyruvate to lactate and malate to oxaloacetate, key steps in the gluconeogenic pathway. It does not directly inhibit glycogenolysis, glucose transport, or glucagon release.

Question 6

A neonate presents with persistent hypoglycemia, lactic acidosis, and hepatomegaly. A deficiency in glucose-6-phosphatase (von Gierke disease) is suspected. The inability to dephosphorylate glucose-6-phosphate in the liver directly impairs which two major pathways of hepatic glucose production?

  1. Glycogenesis and the pentose phosphate pathway.
  2. Glycogenolysis and glycolysis.
  3. Glycogenolysis and gluconeogenesis. (correct answer)
  4. Gluconeogenesis and fatty acid synthesis.
Explanation: Glucose-6-phosphatase is the final enzyme in both glycogenolysis and gluconeogenesis, responsible for hydrolyzing glucose-6-phosphate to free glucose that can be released into the blood. A deficiency traps G6P in the hepatocyte. This prevents the liver from releasing glucose derived from either the breakdown of glycogen (glycogenolysis) or the synthesis from precursors (gluconeogenesis), leading to severe fasting hypoglycemia.

Question 7

A patient undergoes a total pancreatectomy for cancer and is now managed with exogenous insulin. Compared to a patient with type 1 diabetes, this individual is at an exceptionally high risk for severe hypoglycemia primarily due to the complete absence of which hormone?

  1. Somatostatin
  2. Glucagon (correct answer)
  3. Amylin
  4. Pancreatic Polypeptide
Explanation: After a total pancreatectomy, the patient lacks all pancreatic hormones. While insulin can be replaced, the critical loss for hypoglycemia counterregulation is glucagon. Glucagon, secreted by alpha cells, is the first and most important defense against falling blood glucose. Without it, the body must rely solely on the slower and less potent responses of epinephrine, cortisol, and growth hormone, making iatrogenic hypoglycemia much more likely and severe.

Question 8

A patient with a glucagonoma (a glucagon-secreting tumor) undergoes surgical resection. In the immediate postoperative period, the patient develops severe and unexpected hypoglycemia. What is the most likely pathophysiological explanation for this paradoxical event?

  1. Surgical stress caused a massive insulin surge that overwhelmed the remaining counterregulatory systems.
  2. Rapid removal of glucagon's inhibitory effect on insulin secretion led to rebound hyperinsulinism.
  3. The tumor was co-secreting an insulin-like growth factor that was unmasked after glucagon levels fell.
  4. Chronic hyperglucagonemia from the tumor suppressed the normal pancreatic alpha cells, which fail to recover function immediately post-op. (correct answer)
Explanation: When you encounter questions about endocrine tumor removal, think about the chronic adaptations that occur in response to prolonged hormone excess and how these adaptations can cause problems when the excess hormone is suddenly removed. Glucagonomas chronically oversecrete glucagon, which maintains persistently elevated blood glucose levels. Over time, the normal pancreatic alpha cells that would typically secrete glucagon become suppressed through negative feedback mechanisms - essentially, they "shut down" because the tumor is doing their job. When the tumor is surgically removed, glucagon levels plummet immediately, but the suppressed alpha cells cannot instantly resume normal function. This creates a dangerous situation where the patient has inadequate glucagon response to counter normal insulin activity, leading to severe hypoglycemia. Option A is incorrect because surgical stress typically increases counterregulatory hormones and blood glucose, not the opposite. Option B misrepresents glucagon's relationship with insulin - glucagon doesn't directly inhibit insulin secretion in a way that would cause rebound hyperinsulinism. Option C suggests co-secretion of insulin-like substances, which is not a recognized feature of typical glucagonomas and doesn't explain why hypoglycemia would occur specifically after tumor removal rather than being masked before surgery. Remember this pattern: when any hormone-secreting tumor is removed, look for complications arising from the suppression of normal endogenous hormone production. The body's normal regulatory mechanisms need time to recover after chronic suppression, creating a vulnerable period immediately post-surgery.

Question 9

A patient with a history of Roux-en-Y gastric bypass surgery presents with symptomatic hypoglycemia occurring 2-3 hours after meals. This condition, known as late dumping syndrome or reactive hypoglycemia, is caused by:

  1. Rapid transit of carbohydrates into the jejunum, leading to an exaggerated and delayed insulin surge. (correct answer)
  2. Blunted glucagon secretion in response to protein ingestion due to altered gut hormone signaling.
  3. Chronic malabsorption of nutrients leading to depletion of hepatic glycogen stores.
  4. Excessive secretion of incretin hormones like GLP-1, which directly inhibit hepatic glucose production.
Explanation: In patients with Roux-en-Y gastric bypass, ingested carbohydrates bypass the stomach and duodenum and are rapidly delivered to the jejunum. This leads to very rapid absorption of glucose, causing a spike in blood sugar. The body responds with a massive, and often delayed, release of insulin. This insulin peak occurs after much of the glucose has already been cleared, resulting in a subsequent plunge into hypoglycemia.

Question 10

In the counterregulatory response to hypoglycemia, epinephrine contributes to raising blood glucose through multiple mechanisms. In addition to its direct effects on the liver, how does epinephrine augment the substrate supply for hepatic gluconeogenesis?

  1. By stimulating proteolysis in the liver to release amino acids.
  2. By increasing renal glucose reabsorption at the proximal tubule.
  3. By stimulating lipolysis in adipose tissue, releasing glycerol and free fatty acids. (correct answer)
  4. By promoting glycogenolysis in skeletal muscle, releasing free glucose into the circulation.
Explanation: Epinephrine stimulates hormone-sensitive lipase in adipocytes, leading to the breakdown of triglycerides into glycerol and free fatty acids. Glycerol travels to the liver, where it serves as a key three-carbon substrate for gluconeogenesis. While skeletal muscle undergoes glycogenolysis, it lacks glucose-6-phosphatase, so it releases lactate and alanine (from pyruvate), not free glucose, which can then be used by the liver.

Question 11

A patient on a non-selective beta-adrenergic blocker for hypertension is brought to the ED with confusion. Blood glucose is 45 mg/dL after missing a meal. Which clinical finding is most likely to be absent in this patient despite the severe hypoglycemia?

  1. Diaphoresis (sweating)
  2. Pallor
  3. Tachycardia and tremors (correct answer)
  4. Hunger and paresthesias
Explanation: Non-selective beta-blockers (e.g., propranolol) block beta-1 and beta-2 adrenergic receptors. This action masks many of the classic neurogenic warning symptoms of hypoglycemia, such as tachycardia, palpitations, and tremors, which are mediated by catecholamines. However, diaphoresis and hunger are primarily mediated by the parasympathetic (cholinergic) system and are therefore not blocked, often becoming the only prominent warning signs.

Question 12

A patient is treated with a sulfonylurea for type 2 diabetes. They develop prolonged hypoglycemia after accidentally taking an extra dose. Laboratory tests are drawn during the hypoglycemic episode. Which set of findings is most consistent with sulfonylurea-induced hypoglycemia?

  1. High insulin, high C-peptide, low proinsulin
  2. High insulin, high C-peptide, high proinsulin (correct answer)
  3. High insulin, low C-peptide, low proinsulin
  4. Low insulin, low C-peptide, high proinsulin
Explanation: Sulfonylureas stimulate the pancreatic beta-cells to secrete insulin by closing ATP-sensitive K+ channels. This process is unregulated by blood glucose levels. The secreted insulin comes from endogenous production, so for every molecule of insulin released, a molecule of C-peptide is also released. Therefore, labs will show high insulin and high C-peptide. Because the drug drives beta-cell secretion intensely, there is often release of immature, unprocessed proinsulin as well.

Question 13

A patient with chronic alcohol use disorder and malnutrition is found to be profoundly hypoglycemic (35 mg/dL). The metabolism of ethanol increases the cytosolic NADH/NAD+ ratio in hepatocytes. This biochemical change directly impairs counterregulation by inhibiting which specific metabolic process?

  1. The conversion of gluconeogenic precursors like lactate and pyruvate to phosphoenolpyruvate. (correct answer)
  2. The activity of glycogen phosphorylase, thereby preventing hepatic glycogenolysis.
  3. The transport of glucose out of the hepatocyte via GLUT2 transporters.
  4. The release of glucagon from pancreatic alpha cells in response to low glucose.
Explanation: Ethanol metabolism by alcohol dehydrogenase and aldehyde dehydrogenase consumes NAD+ and generates excess NADH. The high NADH/NAD+ ratio inhibits gluconeogenesis by shunting precursors away from glucose production; for example, it favors the conversion of pyruvate to lactate and malate to oxaloacetate, key steps in the gluconeogenic pathway. It does not directly inhibit glycogenolysis, glucose transport, or glucagon release.

Question 14

In the counterregulatory response to hypoglycemia, epinephrine contributes to raising blood glucose through multiple mechanisms. In addition to its direct effects on the liver, how does epinephrine augment the substrate supply for hepatic gluconeogenesis?

  1. By stimulating proteolysis in the liver to release amino acids.
  2. By increasing renal glucose reabsorption at the proximal tubule.
  3. By stimulating lipolysis in adipose tissue, releasing glycerol and free fatty acids. (correct answer)
  4. By promoting glycogenolysis in skeletal muscle, releasing free glucose into the circulation.
Explanation: Epinephrine stimulates hormone-sensitive lipase in adipocytes, leading to the breakdown of triglycerides into glycerol and free fatty acids. Glycerol travels to the liver, where it serves as a key three-carbon substrate for gluconeogenesis. While skeletal muscle undergoes glycogenolysis, it lacks glucose-6-phosphatase, so it releases lactate and alanine (from pyruvate), not free glucose, which can then be used by the liver.

Question 15

A patient undergoes a total pancreatectomy for cancer and is now managed with exogenous insulin. Compared to a patient with type 1 diabetes, this individual is at an exceptionally high risk for severe hypoglycemia primarily due to the complete absence of which hormone?

  1. Somatostatin
  2. Glucagon (correct answer)
  3. Amylin
  4. Pancreatic Polypeptide
Explanation: After a total pancreatectomy, the patient lacks all pancreatic hormones. While insulin can be replaced, the critical loss for hypoglycemia counterregulation is glucagon. Glucagon, secreted by alpha cells, is the first and most important defense against falling blood glucose. Without it, the body must rely solely on the slower and less potent responses of epinephrine, cortisol, and growth hormone, making iatrogenic hypoglycemia much more likely and severe.

Question 16

A 48-year-old is diagnosed with an insulinoma. During a supervised fast, her blood glucose drops to 40 mg/dL, yet her glucagon and epinephrine levels are inappropriately low for this degree of hypoglycemia. What is the most likely explanation for this blunted counterregulatory hormone response?

  1. The tumor co-secretes somatostatin, which potently inhibits both glucagon and epinephrine release.
  2. Intra-islet hyperinsulinemia exerts a powerful paracrine inhibition on pancreatic alpha cell glucagon secretion. (correct answer)
  3. Chronic hypoglycemia causes downregulation of adrenergic receptors on pancreatic and adrenal medullary cells.
  4. The insulinoma has metastasized to the adrenal glands, replacing catecholamine-producing tissue.
Explanation: The primary reason for the suppressed counterregulatory response in the setting of an insulinoma is the direct effect of high insulin levels. Within the pancreatic islet, the pathologically high insulin levels exert a strong paracrine inhibitory effect on adjacent alpha cells, suppressing glucagon release even when hypoglycemia is profound. Insulin also has a central effect that can dampen the sympathetic response, including epinephrine release.

Question 17

Whipple's triad is used to diagnose true hypoglycemia as the cause of a patient's symptoms. It consists of: 1) symptoms consistent with hypoglycemia, 2) low plasma glucose measured at the time of symptoms, and 3) relief of symptoms after glucose is raised. Which part of this triad is most crucial for differentiating hypoglycemia from conditions that mimic its symptoms, such as anxiety attacks or seizures from other causes?

  1. The presence of classic neurogenic symptoms like tremor and palpitations.
  2. The documentation of low plasma glucose concurrent with the symptoms.
  3. The prompt and complete resolution of symptoms after glucose administration. (correct answer)
  4. The patient's subjective report of feeling better after consuming a sugary drink.
Explanation: While documenting low glucose (part 2) is essential, the most specific confirmation that the symptoms were caused by hypoglycemia is their prompt reversal upon glucose administration (part 3). Conditions like anxiety attacks or certain seizure disorders can present with similar symptoms and might even coexist with low glucose by chance. However, these conditions will not resolve immediately and completely upon normalization of blood sugar, making the response to treatment the key differentiator.

Question 18

A 48-year-old is diagnosed with an insulinoma. During a supervised fast, her blood glucose drops to 40 mg/dL, yet her glucagon and epinephrine levels are inappropriately low for this degree of hypoglycemia. What is the most likely explanation for this blunted counterregulatory hormone response?

  1. The tumor co-secretes somatostatin, which potently inhibits both glucagon and epinephrine release.
  2. Intra-islet hyperinsulinemia exerts a powerful paracrine inhibition on pancreatic alpha cell glucagon secretion. (correct answer)
  3. Chronic hypoglycemia causes downregulation of adrenergic receptors on pancreatic and adrenal medullary cells.
  4. The insulinoma has metastasized to the adrenal glands, replacing catecholamine-producing tissue.
Explanation: The primary reason for the suppressed counterregulatory response in the setting of an insulinoma is the direct effect of high insulin levels. Within the pancreatic islet, the pathologically high insulin levels exert a strong paracrine inhibitory effect on adjacent alpha cells, suppressing glucagon release even when hypoglycemia is profound. Insulin also has a central effect that can dampen the sympathetic response, including epinephrine release.

Question 19

A patient on a non-selective beta-adrenergic blocker for hypertension is brought to the ED with confusion. Blood glucose is 45 mg/dL after missing a meal. Which clinical finding is most likely to be absent in this patient despite the severe hypoglycemia?

  1. Diaphoresis (sweating)
  2. Pallor
  3. Tachycardia and tremors (correct answer)
  4. Hunger and paresthesias
Explanation: Non-selective beta-blockers (e.g., propranolol) block beta-1 and beta-2 adrenergic receptors. This action masks many of the classic neurogenic warning symptoms of hypoglycemia, such as tachycardia, palpitations, and tremors, which are mediated by catecholamines. However, diaphoresis and hunger are primarily mediated by the parasympathetic (cholinergic) system and are therefore not blocked, often becoming the only prominent warning signs.

Question 20

The brain adapts to chronic or recurrent hypoglycemia to protect against severe neuroglycopenia. What is the primary cellular adaptation that mediates this protective effect?

  1. A shift in primary energy metabolism from glucose to branched-chain amino acids.
  2. Enhanced anaerobic glycolysis capacity within astrocytes to supply lactate to neurons.
  3. Development of insulin sensitivity in neuronal cells, allowing for insulin-mediated glucose uptake.
  4. Increased expression of glucose transporters (GLUT1 and GLUT3) at the blood-brain barrier and on neurons. (correct answer)
Explanation: When you encounter questions about the brain's adaptation to chronic hypoglycemia, think about how the brain maintains its high energy demands when glucose availability is compromised. The brain is uniquely glucose-dependent, consuming about 20% of the body's glucose despite being only 2% of body weight. The correct answer is D because the primary adaptation involves upregulating glucose transport capacity. During recurrent hypoglycemia, the brain increases expression of GLUT1 transporters at the blood-brain barrier and GLUT3 transporters on neurons themselves. This enhanced transporter density allows more efficient glucose extraction from blood even when glucose concentrations are low, maintaining adequate neuronal glucose supply and preventing severe neuroglycopenia. Option A is incorrect because while the brain can use alternative fuels like ketones during prolonged starvation, it cannot effectively metabolize branched-chain amino acids as a primary energy source. Option B misrepresents the adaptation - while astrocytes can provide lactate to neurons, enhanced anaerobic glycolysis isn't the primary chronic adaptation and would be metabolically inefficient. Option C contains a fundamental error: neurons lack insulin receptors and don't require insulin for glucose uptake. Neuronal glucose uptake depends on concentration gradients, not insulin signaling. For pathophysiology exams, remember that the brain's adaptations to metabolic stress typically involve optimizing existing pathways rather than switching to entirely different metabolic strategies. Focus on glucose transport mechanisms - GLUT1 and GLUT3 are insulin-independent and crucial for brain glucose homeostasis.